Preclinical study identifies new target for recurrent ovarian cancer Posted on 17/04/2023 Antibody-drug conjugate successfully targets B7-H4 Source: Read Full Article Related posts: Health system's online assistant helps patients find the right kind and level of care Man finds shard of glass which has been stuck in his hand for four years How to stay comfortable running in a heatwave Dietary Zinc Linked to Reduced Migraine Risk Post navigation « Spring Covid booster roll-out starts today with five million eligibleA highly sensitive, wearable piezoelectric blood pressure sensor for continuous health monitoring »
